These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36184739)

  • 1. Desmodin and isopongachromene as potential inhibitors of cyclin-dependent kinase 5: phytoconstituents targeting anticancer and neurological therapy.
    Atiya A; Batra S; Mohammad T; Alorfi NM; Abdulmonem WA; Alhumaydhi FA; Ashraf GM; Baeesa SS; Elasbali AM; Shahwan M
    J Biomol Struct Dyn; 2023; 41(16):8042-8052. PubMed ID: 36184739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
    Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
    Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
    J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
    Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
    Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
    J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
    Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
    OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
    Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
    J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.
    Zeb A; Son M; Yoon S; Kim JH; Park SJ; Lee KW
    Comput Struct Biotechnol J; 2019; 17():579-590. PubMed ID: 31073393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
    Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
    Molecules; 2022 May; 27(10):. PubMed ID: 35630545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery.
    Atiya A; Alhumaydhi FA; Sharaf SE; Al Abdulmonem W; Elasbali AM; Al Enazi MM; Shamsi A; Jawaid T; Alghamdi BS; Hashem AM; Ashraf GM; Shahwan M
    Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the discovery of cdk5 inhibitors.
    Glicksman MA; Cuny GD; Liu M; Dobson B; Auerbach K; Stein RL; Kosik KS
    Curr Alzheimer Res; 2007 Dec; 4(5):547-9. PubMed ID: 18220519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics.
    Anjum F; Sulaimani MN; Shafie A; Mohammad T; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Alsagaby SA; Yadav DK; Hassan MI
    RSC Adv; 2022 Mar; 12(13):7872-7882. PubMed ID: 35424745
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Alshehri SA; Wahab S; Almoyad MAA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9463-9474. PubMed ID: 37643015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors.
    Di Stefano M; Galati S; Ortore G; Caligiuri I; Rizzolio F; Ceni C; Bertini S; Bononi G; Granchi C; Macchia M; Poli G; Tuccinardi T
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
    Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations.
    Shafie A; Khan S; Zehra ; Mohammad T; Anjum F; Hasan GM; Yadav DK; Hassan MI
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
    Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
    J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of molecular interaction of Phosphodiesterase 10A inhibition by natural compounds: insights from structure-based screening and molecular dynamics simulations.
    Ali Alshehri S; Alsayari A; Wahab S; H Alqarni M; Sweilam SH; Khalid M
    J Biomol Struct Dyn; 2024; 42(22):12596-12607. PubMed ID: 37850684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.